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Abstract
At the end of January 2020, SARS-CoV-2 started escalating worldwide. COVID-19 
can exert its effects on immunity, inflammation, and multi-organ system disease, 
common denominators with the burn injury. The pandemic required major efforts to 
Burn centres in order to preserve burn patients’ care and contribute to the health care 
response. In our Burn Unit we autonomously developed a protocol for patients accep-
tance and surveillance of the hospitalized ones and the personnel. We briefly describe 
our experience with six cases of burn patients infected by SARS-CoV-2 highlighting 
the overlap between medical treatment of burn patients and COVID-19 patients. 
To avoid viral spreading epidemiologic control is essential, especially preventive 
measures such as isolation of infected patients and identification of the source of 
infection. In our surgical practice, we increased the use of enzymatic debridement 
avoiding procedures with a high risk of viral particles spreading. Personnel protection 
and dedicated pathways have been planned, optimizing air circulation and disinfec-
tion. Vaccines represent the best hope for the global population to stop the viral 
spread, despite new variants outbreaks.
Keywords: COVID-19, Burn Unit, Burn Patients, Preventive measures,  
Clinical and surgical management, experience
1. Introduction
1.1 Background
At the beginning of December 2019 was reported for the first time, in the city 
of Wuhan, Central China, a pneumonia of unknown origin, named “coronavirus 
disease 2019” (COVID-19), caused by an agent initially known as 2019 novel 
coronavirus (2019-nCOV) and later referred as severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) [1].
1.2 Epidemiology
Since the end of January 2020, SARS-CoV-2 started escalating worldwide 
until it was declared a pandemic disease by the World Health Organization on 
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March 11th, 2020. By the end of May 2020, the disease reached 188 countries 
causing nearly 370000 deaths. In Italy, clusters of cases were detected on 21th 
and 22th of February 2020 only in the regions of Lombardy and Veneto. At the 
beginning of March 2020, the virus was present in all regions of Italy leading the 
government to quarantine the whole population. For more than a year, Italy has 
been burdened by a huge number of cases and deaths with a related increase in 
hospitalizations and ICU admissions leading to a consequent constant hard stress 
for the National Health System. Meanwhile, scientists from all over the world 
intensively strived to unravel virus characteristics and develop new therapeutic 
and preventive approaches.
1.3 SARS-CoV-2 and burned patients
Since the COVID-19 epidemic onset, SARS-CoV-2 demonstrated a major conta-
gious capability [2] with recent findings demonstrating possible similar pathophysi-
ological features with SARS-CoV [3].
The mechanism of infection among humans is based on inhaled respiratory 
droplets with the virus replicating in the nasopharyngeal mucosa, spreading then 
into the lungs with lower respiratory tract infection capability. Close contact could 
also represent an infection source through mucosal surfaces of the nose, mouth, 
and eyes [4, 5]. Besides, there is also the chance of aerosol transmission in a closed 
environment.
Viremia, after the entrance of the virus in the circulatory system, can provoke 
secondary involvement of various target organs (e.g., heart, kidney, and central 
nervous system) with pathophysiological effects of SARS-CoV-2 ranging from acute 
lung injury to systemic and pulmonary hypertension, heightened inflammation, 
vascular hyperpermeability, coagulopathy and cardiovascular and gastrointestinal 
complications [3, 6].
Among the various types of trauma, extended burns can be considered as one 
of the most dramatic ones, characterized by a state of hypermetabolism with a 
catabolic shift, a state of hyperdynamic circulation and inflammation, subsequently 
linked to multiorgan failure and poor outcome [7, 8]. Additional pathophysiologic 
changes include vascular leaking mediated by polymorphonuclear activation and 
hemodynamic instability [9]. Moreover, immunosuppression, reported in major 
burn injuries [10], can determine a higher risk of infections which in turn can 
degenerate into sepsis, multiorgan failure and death.
Patient’s age, total body surface area with burns, inhalation injury, and arising 
organ dysfunction are some of the principal prognosis predictors of burns [4, 11, 12].
In this way, COVID-19 can exert its effects on immunity, inflammation, and 
multi-organ system disease, common denominators with the burn injury, especially 
because SARS-CoV-2 infection might be a concurrent disease in a patient present-
ing to the medical attention for burns, needing immediate evaluation and medical 
attention even before COVID- 19 can be ruled out.
2. Burn unit experience during the pandemic period
COVID-19 disease, when symptomatic, usually presents itself with fever, cough, 
and myalgia or fatigue. Less common presentations are sputum production, sore 
throat, nasal congestion, anosmia, headache, hemoptysis, and diarrhea [13]. The 
severe pattern of evolution is characterized by worsening dyspnoea with hypoxemia 
and lymphopenia after which septic shock, ARDS, metabolic acidosis, and coagula-
tion dysfunction can rapidly develop [14].
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The actual pandemic pushed Burn centres efforts forward, keeping a fair bal-
ance between preserving burn patients’ care and contributing to the health care 
response.
Due to the lack of really effective therapies and prevention measures such as 
vaccination during the virus initial outbreak, the major and most effective ways for 
disease spreading control were the isolation of affected patients, tracing of infected, 
hands hygiene, respiratory airways protection, and surface sterilization [15].
Our Burn Center, located in the North-East of Italy, a third level facility respon-
sible for the acceptance and treatment of all major burns in an area with a popula-
tion of approximately 5 million people, consists of three separate units: an ICU, a 
semi-ICU, and a Burn and Plastic Surgery Ward. There is also an outpatient clinic 
for post-discharge follow-up and small interventional procedures.
Due to the high demand of personnel and resources in the semi-ICUs and ICUs, 
all non-emergent activity was reduced in order to allocate the resources needed. In 
Plastic Surgery, only major oncological and trauma cases were scheduled [16]. Our 
Burn Unit reduced its elective activity of correction of burn sequelae. However, 
urgent and emergent activities greatly increased at the beginning of the pandemic 
since burn patients could not be accepted by all other centres in Italy.
The incessant incoming of patients from different locations within the pandemic 
epicenter represented an increased risk both for patients in the Burn Unit and 
for healthcare workers, due to COVID19 rapid spreading inside and outside the 
University Hospital.
In order to face the risk of viral spread, since the beginning of the emergency 
period, we autonomously developed in our Burn Unit a protocol for the acceptance 
of all the new patients and the surveillance of the hospitalized ones and the person-
nel, with distinctions made for the pediatric population [17]. These measures were 
later followed by the general prevention and management indications established 
by the Medical Direction of our University Hospital. Both these protocols were in 
accordance and regularly updated with the most recent Italian Government and 
International literature guidelines [18, 19].
2.1 Burn unit admission management and COVID-19 protocol
The burn-injured patient is firstly transferred from the place of injury to the 
closest hospital with an emergency facility. Here, the first treatment is provided 
to the patient. Meanwhile, our Unit is activated and we give our first telephone 
consultation, predisposing the transfer to our facility if deemed necessary.
During the pandemic, non-essential visits to inpatients were suspended. To 
partially compensate for the loss of direct contact, we provided our patients with 
the possibility of phone or video calls, improving the communication of the medi-
cal personnel with their relatives about clinical conditions and future therapeutic 
programs.
Cornerstones of our admission protocol are the use of PPE, patients’ his-
tory, rapid disease screening and identification in a dedicated room until the test 
response and further patient isolation with frequent reevaluations during the 
following 14 days after admission in the BU.
Patient admission in our centre is performed exclusively in the operating room, 
using PPE when necessary [20]. All patients referred to our Burn Unit, before 
admission to the Ward, semi-ICU and ICU, must be tested through RT-PCR naso-
pharyngeal swab in the sending hospital when the response timing does not inter-
fere with patient’s care or in our hospital.
Immediately after collection, samples are sent for examination at the 
Microbiology lab and the results are available in about 90 minutes.
Trauma and Emergency Surgery
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In addition, only for pediatric cases, also the caregiver is tested: outside the 
operating room if the arrival of the patient and the caregiver is simultaneous, in the 
monitoring room if it is delayed.
A history of fever, cough, other COVID-19 presentation symptoms [13] or 
contact with suspected or confirmed COVID-19 cases, are the first indicators of the 
necessity of isolation of a patient even if the test performed is negative.
During the wait for the result, the patient is treated as a suspect case, in a dedi-
cated room or in the operating room, if intubated.
Chest X-ray and routine panel of blood tests including C-Reactive Protein are 
performed in patients requiring admission, regardless of symptoms.
Moreover, hospital personnel employs all the appropriate protections according 
to the specific-setting contagion risk [21, 22], which, in particular, is higher during 
aerosol-generating procedures as collection of diagnostic respiratory specimens for 
COVID-19, intubation, extubation, manual ventilation, suctioning of the respira-
tory tract, tracheostomy, bronchoscopy and surgery [23, 24].
In the case of a ventilated patient, we also perform a BAL which can allow the 
detection of a positive case even with a negative swab result. At the end of the 
admission procedure, the patient is managed according to the test result (Table 1). 
If the patient is intubated, during the test waiting period he is not moved from the 
operating room with any more emergencies treated in the same operating block in 
order to avoid contamination risk to other health workers and patients.
In some cases, when the number of required tests inside the Hospital is substan-
tial, particularly in the period of acute emergency when the waiting time for the 
result was prolonged, the non-intubated patient could be temporarily moved to a 
dedicated and isolated room equipped as a Burn Unit room.
In the case of a pediatric positive patient and a negative caregiver, only the 
patient is hospitalized in a “COVID-19 room”, a room designed for positive patients 
outside Burn Unit, supplied with the same equipment as the Burn Unit rooms and 
assistance guaranteed by Burn Unit personnel.
Instead, if the pediatric patient is negative and the caregiver positive, the patient 
is hospitalized in the monitoring room for up to 48 h and a new caregiver is desig-
nated. The former caregiver is invited to return home and adopt isolation measures 
keeping in contact with the local authorities. The Burn Unit physician has to inform 
the Epidemiology service of the caregiver positivity. The new caregiver and the 
patient have to be tested with the nasopharyngeal swab and if the result is negative 
they are both admitted outside the Burn Unit and placed in the isolation room for 
14 days.
If the pediatric patient is intubated, no caregiver is included as in ICUs access is 
denied to anyone who does not belong to healthcare personnel.
Confirmed SARS-Cov-2 affected patients are admitted to the COVID-19 Unit, in 
separate airborne infection isolation rooms. Critical Burn patients are placed in the 
COVID-19 ICU.
Infectious disease specialists are consulted early with constant participation in 
patient care.
Burn patients who develop symptoms after admission are isolated and undergo 
swab PCR analysis and chest X-ray. Isolation is maintained until definitive results 
are received.
Negative patients are finally moved to the Burn Unit and quarantined for the 
following 14 days in a single-bed room. During this period, they are tested daily 
for fever and COVID-19-like symptoms. These measures are also effective for the 
caregiver of the pediatric patient. Moreover, a second nasopharyngeal swab is 
performed after 48 h in suspect cases and every 7 days after admittance, accord-
ing to the fact that incubation period of SARS-CoV-2 is estimated to be 3–7 days 
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with a range period from 2 to 14 days [25]. Both patients and caregivers are not 
permitted to leave the Burn Unit.
The temperature of all staff is measured at the entrance and exit from the Unit.
Unnecessary meetings are avoided with the preference given to the video 
conference modality.
On discharge, telemedicine follow-up is emphasized with special attention to 
rehabilitation.
After the initial viral pandemic spreading, in which all elective activity was 
suspended, we progressively began to reschedule this activity since May 2020. In 
order to achieve it, we have decided to screen patients first by phone and again 
immediately before the hospital admittance for travel history, presence of affected 
family members, evidence of fever or any respiratory tract symptoms in the previ-
ous weeks. In addition, asymptomatic patients undergo RT-PCR Sars-CoV-2 test 
before hospital admission.
2.2 Burn unit COVID-19 case series
Since the pandemic began, the main goal of our protocol was to preserve burn 
patients from infection and to avoid viral spread in such a delicate unit.
In the last year, from the beginning of the pandemic, 93 patients were hospital-
ized in our Burn Unit, including six cases of burn patients affected by SARS-CoV-2: 
Table 1. 
Acceptance protocol for pediatric and adult patients admitted to Padua university hospital burn unit.
Trauma and Emergency Surgery
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three of them were hospitalized with a molecular swab positive for COVID-19, 
while three of them were infected during the hospitalization (Table 2).
In April 2020 an extensive burned patient was the first to test positive for 
COVID-19.
She was a 56-year-old female who got burned after a domestic accident (explo-
sion of a gas cylinder) on April 5th 2020 with 70% of TBSA. She was immediately 
intubated, a urinary catheter was introduced, a central line was put and fluid 
resuscitation was immediately commenced.
She reported a 70% TBSA burn involving face (II degree burn), neck, trunk, and 
upper and lower limbs (III degree burns). Once she arrived in our operating room, 
she immediately underwent surgical debridement of all third-degree burns and 
xifo–pubic and both upper limbs fasciotomies were performed. She also underwent 
enzymatic debridement (Nexobrid®) on her third-degree burns on the neck, 
shoulders, and abdomen.
A molecular swab and a BAL were performed at the arrival in the operating 
room and the patient stayed there until the result showed positivity for SARS-
CoV-2. Finally, the patient was transferred to our COVID-19 ICU. Before the 
burn accident, the patient had only a mild fever (38°C), with no other symptoms 
reported. She got infected by her sister with whom she lived.
Once she arrived in our COVID-19 ICU her vital parameters were stabilized and 
she immediately underwent specific treatment for burn patient: intravenous fluid 
resuscitation with Ringer lactate’s solution according to Parkland formula, empiric 
intravenous antibiotics, Low Molecular Weight Heparin (LMWH) 4000 UI once a 







































Features of our Covid-positive patients.
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day, analgesic therapy and human endovenous Immunoglobulin (Pentaglobin®). In 
order to stabilize the vital parameters, it was necessary to perform blood and plasma 
transfusions and to administer noradrenaline. She was also set on an air fluidized 
bed (Clinitron®) for extensive burns of her back.
Initial assessment included a routine blood test, Arterial Blood Gas (ABG) every 
two hours, chest x-ray twice a day and rectal swab searching for MDROs.
Blood tests showed mild leukocytosis (12,02 10^9/L), implementation of PCT 
(0,65 ug/L), important augmentation of myolysis markers (P-CPK 5.813 U/L, 
P-myoglobin 3.814 ug/L).
Because of the important muscular necrosis, she rapidly developed acute kidney 
insufficiency and needed immediate CVVH-DF substitutive renal therapy.
Even though she initially had no Covid-like symptoms but fever, her chest x-ray 
showed an interstitial involvement, her lungs were less expanded and her costo-
phrenic sinuses were poorly evaluable. Because of the risk of ARDS, fluid resuscita-
tion has been kept lower than a 70% TBSA burn patient would necessitate.
During the hospitalization, several cutaneous swabs were performed and 
intravenous antibiotic treatment was changed based on antibiograms.
Blood and plasma were transfused routinely both during surgery and 
hospitalization.
Medical treatment of burn patients and COVID-19 patients shows an overlap.
Treatment with LMWH is mandatory because both burn condition and COVID-
19 infection increase the risk of thrombosis.
Significant inflammation is present in patients with SARS-CoV-2 infection. 
There is the elevation of IL-6 levels, C-reactive protein, erythrocyte sedimentation 
rate, and fibrinogen. Since the tropism of the virus is for ACE2 receptors, this deter-
mines endothelial cell activation and disruption of the antithrombotic state [26].
Broad-spectrum intravenous antibiotics are administered both for the increased 
risk of sepsis in burn patients and prophylactically in COVID-19 patients to avoid 
opportunistic infections.
Besides this treatment, which is common in burn patients and COVID-19 
patients, she also received specific treatment for COVID-19 pneumonia. In order to 
improve her ventilation, she was set in a prone position leading to a slow improve-
ment of her gas exchanges [27]. The change to prone position generates a more even 
distribution of the gas–tissue ratios and a more homogeneous distribution of lung 
stress and strain. It is also accompanied by an improvement in arterial blood gases, 
due to a better overall ventilation/perfusion matching [3].
It was then started endovenous corticosteroid therapy, with the goal of improv-
ing gas exchanges. Corticosteroid therapy given to COVID-19 patients could have 
a favorable effect by reducing pro-inflammatory cytokines, decreasing lung vas-
cular permeability, improving epithelial barrier integrity, and promoting alveolar 
oedema fluid clearance [28].
The patient also started medical treatment with Chloroquine/hydroxychloro-
quine (CQ/HCQ ). Possible mechanisms of action of HCQ are multiple and not fully 
understood. It probably reduces viral entrance by increasing endosomal pH and 
inhibits glycosylation of the cellular ACE2 receptor, interfering with viral binding in 
the lungs [29].
On the twelfth day of hospitalization, her swabs and BALs were negative and the 
patient showed no more COVID-19 positivities until her last day of hospitalization.
After the negativization of two consequent BALs, the patient was transferred 
to a non-COVID-19 ICU, according to the fact that her clinical conditions required 
ICU treatment. In fact, she stayed feverish with temperature oscillating in a range 
from 37.5°C and 39°C, her chest x-rays showed pleural effusion and her blood tests 
revealed an overall augmentation of inflammatory parameters.
Trauma and Emergency Surgery
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During the hospitalization, her general conditions were initially quite stable but 
she slowly developed a septic status, which led the patient to death on her 105th day 
of recovery.
From a surgical point of view, the day after the hospitalization the patient 
underwent a massive surgical debridement of all burned areas, removal of proteo-
lytic enzymes, and a total body change of dressing.
Frequent change of dressings in a dedicated operating room was planned 
(three times a week) and the patient underwent several surgical debridements and 
homologous and autologous skin grafting procedures.
In order to avoid long-term intubation complications, on the 5th day after 
hospitalization a tracheostomy was performed.
During hospitalization, we assisted to a gradual re-epithelialization of the 
burned area, with total healing of her upper left limb but the permanence of not 
fully healed areas on her chest and dorsum.
Our second COVID-19 positive patient was a 73-year-old man who set 
himself on fire with turpentine once he found out that his wife had contracted 
COVID-19 infection. His medical history included blood hypertension, diabetes, 
and depression.
The patient lived in Bergamo, one of the worst-hit cities by COVID-19 in Italy. 
He immediately was transferred to his city ER, where he was stabilized, intubated 
and a BAL was performed with a positive result. The day after, May 7th 2020, he 
was transported by helicopter to our dedicated operating room, where a new BAL 
was performed.
He had II and III degree circumferential burns on his lower limbs, III degree 
burns on the perineum and scrotum, III degree burns on the half of the flanks, 
chest, and left side of the back, III degree burns on half neck and upper limb with a 
TBSA of 60%.
The patient was immediately transfused with plasma and underwent double 
decompressive fasciotomies on his right lower limb. Then surgical and enzymatic 
debridement was performed on all third-degree burns.
The patient was then transferred to our COVID-19 ICU.
As he showed no COVID-19 symptoms, no pneumonia, and initial negative 
BAL, a BAL per day was repeated for the next three days and all of them resulted 
negative. It was also performed a serological test that showed high IgG levels and 
low IgM levels, a sign of a previous positivity.
As his clinical condition required an ICU, the patient stayed in our COVID-19 
ICU, even though he did not develop a COVID-19 infection, and never contracted it 
during his hospitalization in COVID-19 ICU.
In his hospitalization in COVID-19 ICU, the patient was set on an air fluid-
ized bed (Clinitron®) as adjuvant therapy for his back burns, and standard 
treatment for burn patient was started: hydration with Ringer lactate’s solution 
for the first 24 hours, then with rehydration solution, antithrombotic therapy 
with LMWH, broad-spectrum intravenous antibiotics according to microbial 
cultures, Immunoglobulin therapy for three days (Pentaglobin®) and antalgic 
therapy.
His vital parameters were monitored, water balance was kept positive, and 
specific parenteral alimentation rich in proteins and oligo-elements was started.
Routine blood tests and x-rays were made and various microbiological samples 
were sent.
Thanks to the ICU care we assisted in a gradual recovery of vital parameters, 
stabilization of the hemodynamic system, and the restoration of spontaneous 
breathing.
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From a respiratory point of view, the patient has been intubated until the 15th of 
May, when a tracheostomy was performed and he was ventilated through it. Since 
the 28th of June, he has been spontaneously breathing.
Hemodynamically he required therapy with norepinephrine for about 
one month.
His recovery in COVID-19 ICU, which in the meantime returned to a non-
COVID-19 ICU as the first wave of COVID-19 was about to end, lasted 52 days and 
then he was transferred to our Burn Unit.
During his hospitalization in our Burn Unit, we assisted in gradual healing and 
re-epithelialization of all burned areas and the patient was going to be transferred 
to the Burn Centre of his belonging region for the continuation of treatment.
On the 19th of August the patient complained of dyspnea, he had a fever (41°C) 
which did not respond to antipyretics. His saturation was 86% with 6 L/min of 02, 
his blood pressure was 72/32 mmHg, heath rate 105 bpm, and respiratory rate 42 
breaths per minute. A septic shock was developing. He was immediately transferred 
to the ICU and intubated but he died some days later because of the worsening of 
the septic shock.
It is clear that death in this patient is related to the severity of his burns and not 
to COVID-19.
Nevertheless, this case remarks once again how fundamental is the management 
of a COVID-19 burn patient since the beginning, with the use of a dedicated operat-
ing room and the recovery in a COVID-19 ICU.
In the month of October 2020, all of Italy was affected by the second wave 
of COVID-19, with the viral spread and the crescent burden on ICUs. This led to 
the diffusion of the infection inside the hospitals and the genesis of clusters of 
infection.
As a matter of fact, between October 8th and November 30th 2020, two of our 
patients got infected by the virus several weeks after their hospitalization.
Thanks to our protocol, which contemplates the repetition of antigenic and 
molecular COVID-19 swabs weekly, we managed to identify and immediately 
isolate patients affected by COVID-19, in order to reduce the spread of infection 
inside our Burn Unit.
None of our patients who contracted the infection showed any COVID-19-like 
symptoms. They had only a mild fever, which wasn’t imputable to the virus. In fact, 
all of them had a mild augmentation of inflammatory parameters and microbiologi-
cal growth (Pseudomonas aeruginosa above all) on their burns. In fact, fever is one of 
the most frequent symptoms in burn patients.
It is curious that they had their first positive molecular swab on the 8th of 
October and continued to alternate positive and negative molecular swabs until the 
30th of November.
These patients never showed any significant symptoms and had been isolated 
in a single room for all the positivity period. Further examinations were made, in 
fact, a sputum culture examination was performed and within approximately one 
week we had the result: no SARS-CoV-2 growth. So all the molecular swabs which 
resulted positive after the sputum examination were false positive and the patients 
were not considered contagious anymore.
Until an effective circumscription of positive cases has been achieved, it was 
taken the hard decision not to hospitalize other burn patients which did not come, 
of course, from our ER.
Spatial isolation, the use of PPE, the weekly screening program, and the dis-
infection of all common spaces were fundamental to circumscribe the COVID-19 
cluster which was born in our Burn Unit.
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Once safety was finally achieved it was restarted regular hospitalization, always 
according to our COVID-19 protocol.
The third COVID-19 burn patient was a 51-year-old female who burned her face 
due to a backfire, reporting only II-degree burns. At the arrival, an ENT consulta-
tion was made and it stated intubation wasn’t necessary. A molecular swab was 
made and it tested positive for COVID-19. The patient was completely asymptom-
atic and was hospitalized in our Burn Unit.
She underwent surgical debridement and an amniotic membrane grafting was 
performed. Her hospitalization lasted for 6 days and then she was dismissed.
Our last burn patient affected by COVID-19 was a 25-year-old female.
She had contracted the infection ten days before the burn and she was in home 
isolation, as her conditions did not require hospitalization. Her home treatment 
included antipyretics, Azithromycin once a day for six days, no LMWH or cortico-
steroids were necessary. No other significant medical history was reported.
Due to this injury, she reported second-degree burns on her neck and 
cheeks; third-degree burns circumferential on her upper limbs, second-degree 
on her chest and breasts; second-degree on her abdomen with a TBSA of 41%. 
We decided to immediately perform enzymatic debridement with Nexobrid® 
(Figure 1), and after 24 hours we performed coverage within homologous 
skin grafts and amniotic membrane. The patient was then transferred to a 
COVID-19 ICU.
During her hospitalization in ICU, she did not present any COVID-19-like symp-
toms and her BALs negativized five days after her hospitalization, so no specific 
treatment for COVID-19 was started and she received standard therapy for burn 
patients. In two weeks the patient was stabilized and transferred to our Burn Unit 
and her skin injuries were definitely closed by an autologous skin graft.
This case series reported how the novel SARS-CoV-2 afflicted our Burn Unit and 
how we managed to adapt our Burn Unit admission because of the pandemic. It is 
important to underline that none of our patients affected by COVID-19 ever devel-
oped interstitial pneumonia and so COVID-19 infection did not directly influence 
the outcome of our patients.
What actually was influenced by the pandemic was the management of the 
patient, the preparation of the operating room, and the surgical act itself.
2.3 Surgical treatment of Sars-CoV-2 patients
For most burn patients coming to the OR, the need for surgical intervention 
is imperative. Patients urgently admitted to any Burn Unit generally need imme-
diate transfer to the OR for the primary care of their wounds and, mostly, will 
need subsequent surgical reassessments and re-interventions until an acceptable 
cover of the wounds has been achieved and the patient may be followed up as an 
outpatient.
Figure 1. 
Third degree burn abdoment and chest 4 hour after enzimatic debridment with Nexobrid.
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The urgent admission and the subsequent surgical revisions expose medical 
personnel involved in burned patient care to an increased risk of contracting SARS-
CoV-2 due to prolonged exposure in the OR and in the Burn Unit itself. Besides, the 
exposure risk also applies to the other patients admitted to the OR or the wards due 
to proximity.
As vaccine rollout proceeds, more and more people are getting immunized to 
SARS-CoV-2, however, as vaccination efforts are still underway, screening at admis-
sion, isolation protocols for positive patients and safe surgical and anesthesiologic 
procedures for the personnel are still to be enforced to ensure spread avoidance.
In our experience, the protocol enforced to screen SARS-CoV-2 patients entering 
our ward has worked fine in avoiding admission of positive patients and in avoiding 
spreading of the infection among inpatients and to or from healthcare workers [17].
In general, struggling with a pandemic and having hospitals overwhelmed by 
SARS-CoV-2 positive patients in various degrees of severity, required careful orga-
nization, and eventual re-organization, of the health care staff activity from nurses 
to medical doctors to support personnel in order to avoid exhaustion of resources. 
This is especially true for surgical equipment which cannot be easily replaced with 
new, less trained staff or by staff taken from other branches of medicine without 
the risk of reducing senior surgical expertise hence the standard of care. From here, 
the need to work on skeleton personnel in order to spare as many units as possible in 
case of health care personnel contagion. In general, this type of approach has been 
required to minimize almost all elective surgical activities and to postpone them 
to the moment when contagion levels start, slowly, to reduce in number. The only 
elective patients that kept on being admitted were the oncological ones and only 
after submission of a negative SARS-CoV-2 RT- PCR test dated no more than 3 days 
before admission. However, obviously, emergent patients did not disappear during 
COVID-19 pandemic and their management has been the greatest concern of all in 
order to guarantee assistance, but to avoid excessive personnel exposure.
In Italy, the major medical societies involved in the care of surgical patients have 
produced indications for the management of potential SARS-CoV-2 patients [30] 
which often are the backbone of each hospital-specific protocol.
As the emergent need for surgery does not allow time to wait for SARS-CoV-2 
swab results, all patients admitted in emergency must be treated as if they were 
positive.
As, usually, transport is needed to bring the patient from the ward or from else-
where to the theater, clear and pre-designed pathways should be available. These 
paths should be the shortest possible and the most isolated possible, as this is clearly 
not always possible, anyone crossing these paths should be alerted preemptively or 
these paths should be cleared before passage and sanitized afterwards. Transport 
personnel should be trained to wear appropriate PPE at all times.
In general, patients going to theater should not stop anywhere for any reason 
but should be brought to the designated theater where all procedures pre, peri, 
and post-operational should be performed and that designated theater should be 
the one closest to theater entry in order to minimize transit contagion risk. Entry 
and exit pathways to the theater should be different from negative patients’ routes. 
Potentially positive patients should wear the protective masks until anesthesiologic 
procedures for tubing begin, otherwise, if there is no need for intubation, the 
protective mask should be worn at all times. Clearly, the personnel that will care for 
the patient, needs to be trained in donning, doffing, and in the disposal of protec-
tive equipment (Figure 2).
In the OR minimal personnel should be allocated to a single infected case in 
order to minimize exposure and, if the case spans more than one shift, this could 
mean working after hours for the equipment involved. All personnel receiving the 
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patient should be wearing appropriate PPE. All non-necessary material must remain 
outside the OR including medical records which may be consulted either by doffing 
or by personnel non involved in the OR and then communicated inside the OR.
OR should be negative-pressurized with a high air exchange cycle rate. Materials 
available should be ready on a case-by-case basis before the procedure begins and, 
once it starts, all efforts should be made to use what is available in order to reduce 
to the least possible entry and exit of personnel to and from the OR. All trolleys 
should be replaced with dedicated ones in order to avoid possible surface contagion 
for procedures to come afterwards. Personnel must be reduced to the minimum 
number possible to perform the planned operation.
Anesthesiologists should have planned their strategy in advance in order to 
minimize risks associated with complex intubation procedures and techniques with 
the highest chance of first-time success should be used to reduce excessive manipu-
lation of the airways. All staff must wear full PPE and these should be replaced 
after completing the procedure, especially if that has been complex.
More liberal use of intubation is acceptable to avoid risks associated with non-
invasive ventilation. RSI could potentially reduce the need for manual ventilation 
and potential aerosol spreading, which could however be reduced by using small 
current volumes in manual ventilation. HEPA filters should be put between the 
patient’s expiratory limb and the ventilator machine and between the patient and 
the gas sampling tube and replaced after each use.
As all materials should be ready before the procedure starts, all efforts must be 
made to use the material available. Entering or exiting the room should be discour-
aged at all times. Any need for additional material should be addressed by person-
nel outside the OR. Surgical masks are replaced by FFP2 all the remaining donning 
should be performed as protocols indicate. The patient is dressed according to the 
procedure to be performed.
For what concerns the procedure, no consensus exists on whether laparoscopy 
should be used or should be contraindicated [31]. There is the theoretical possibility 
of spreading the virus through smoke produced by energy devices, but this has not 
been demonstrated for SARS-CoV-2. The same applies to energy devices used in 
open surgery. No formal contraindication exists to perform laparoscopic procedures 
in SARS-CoV-2 patients either positive or suspected, however, all precautions must 
be applied to reduce potential exposures including reducing the use of electrosurgi-
cal devices, applying smoke evacuators and HEPA filters to exhaustion of surgical 
smoke, reducing pneumoperitoneum pressures [32] and, finally, deflating the 
abdomen using suction or smoke evacuation devices instead of letting pneumoperi-
toneum out from trocar incisions in the OR [33].
Figure 2. 
Preparation to a Covid burned patient surgery with all protective disposable.
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Otherwise, we need to perform a protection colostomy for burn legs in our 
second COVID-19 patient and we preferred to perform it by open laparotomy due 
to efforts to avoid gas diffusion on COVID-19 tissues and the presence of abundant 
abdomen’s free liquid [34].
After the procedure, enough time should be allowed for air exchange in the OR 
according to the exchange cycle rate of the theater to avoid cross-contamination. 
All environments in which the patient has transited should be carefully sanitized. 
All waste should be disposed of in designated containers and should transported 
wearing full PPE.
2.4 Burned patient swab surveillance
Screening swabs on the healthcare workers were scheduled weekly while on 
hospitalized patients twice a week. In the first 6 months from the beginning of 
the pandemic, no outbreak occurred in the ward, neither among staff nor among 
patients.
For scheduled surgical interventions instead, a telephone triage was performed 
to find out if in the previous 2 weeks the patient had developed any symptoms 
compatible with a possible COVID-19 infection, such as fever, cough, breathing dif-
ficulties, asthenia, anosmia, or ageusia. If the patient did not report any symptoms 
or known positive contacts, molecular swabs were performed in the 96-72 h before 
hospitalization, requiring the patient to be isolated at home after the execution [16].
In early October, rapid antigenic swabs began to be used mainly by the infec-
tious disease department and the emergency room. During the second week of 
October a small Coronavirus outbreak involving two healthcare workers as well as 
two patients, developed inside the Burn Unit. This led to the request to the infec-
tious diseases department for a supply of rapid antigenic swabs, to obtain a faster 
and more efficient screening of patients and medical staff.
Up to that time, the standard hospital procedure, in case of unprotected contact 
with a patient positive for COVID-19, included the execution of a molecular swab: 
immediately after contact, on the 5th and the 10th day.
During this screening period, the operator, if asymptomatic and tested negative, 
was not required to stay in home isolation.
The main problem with this screening routine based on molecular swabs was 
the report timing. In fact, at that time, a screening swab, given the large amount of 
work to which the laboratory was subjected, was rarely reported before 2–3 days.
These timing of execution, considering the incubation period and the high 
percentage of asymptomatic patients with the COVID-19 infection, subjected the 
staff, who had to work daily with positive patients, to a concrete risk, if they had 
contracted the virus, to act as vectors before the swabs detected their positivity.
To reduce this risk, we decided that the screening for the viral detection in the 
major burn centre had to be carried out by performing a double swab: antigenic and 
molecular at the same time.
Although at that time many studies had already reported an antigenic swabs 
sensitivity varying between 30% and 80%, considerably inferior compared to the 
molecular swabs one, reported around 97%, the speed of execution made it possible 
to anticipate possible isolation by a few days, thus reducing the possibility of any 
intra-hospital infections and the onset of new outbreaks [35–37].
With the double swab method, screenings continued to be carried out every 
7 days on healthcare workers, twice a week (usually on Monday and Friday) on 
hospitalized patients, at 0–5-10 days for unprotected contacts and as needed for 
personnel or patients who presented suggestive symptoms such as fever, arthralgia, 
anosmia or malaise.
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The “double-swab” screening continued till the end of February when the 
healthcare workers got vaccinated. From that moment, weekly, only molecular 
swabs are performed, while “double-swabs” screening is still carried out nowadays 
for unvaccinated hospitalized patients.
From the beginning of this double swab protocol, no patient got infected during 
their hospitalization. We registered four cases of SARS-CoV-2 infection between 
healthcare personnel, all of them immediately quarantined with none of them 
contracting the infection in the workplace.
3. Therapeutic consideration in a COVID-19 burn patient
Burn-injured patients are deeply affected in nearly all their vital functions with 
pathophysiologic changes that can range from hemodynamic instability to altered 
metabolism, hypothermia, and, more importantly, airway and pulmonary impaired 
functions.
SARS-CoV-2 has represented in Italy an impressive public health threat, rapidly 
spreading among regions with Lombardy and Veneto as epidemic centres. Because 
of the high viral infectious rate and its capability to damage several organs, espe-
cially the lung with particular severe pneumonia, effective prevention and treat-
ment are essential [12].
Various treatment options are being tested, with a variety of studies investigat-
ing the utility of some off-label drugs. Currently, the major way to avoid virus 
spreading is epidemiologic control through preventive measures such as isolation 
of infected patients and identification of the source of infection. All categories of 
people are susceptible to SARS-CoV-2 but most severe cases are recognized in the 
elderly patients and those with underlying diseases or immune dysfunctions [6, 13]. 
Burn injuries must be considered similar to the above-mentioned conditions for 
their intrinsic immune and multiple organ dysregulation, in the context of a general 
severe illness affecting all vital functions [14].
The fast COVID-19 spread from China to European countries such as Italy, and 
particularly the region in which our centre is located, therefore imperatively required 
the implementation of every procedure and admission protocol in our Burn Unit.
COVID-19 treatment guidelines are continuously updating based on revis-
ing, legitimate national and international guidelines for optimal management. 
Antivirals such as Kaletra, Favipiravir and Remdesivir have been used by infectious 
disease consultants but are not part of our COVID-19 treatment guidelines yet. 
Oseltamivir or Ribavirin are not used any longer. Hydroxychloroquine has not been 
used anymore in the treatment of COVID-19 patients.
Interferon-Beta and/or IVIG have been given in case of excessive inflammatory 
responses, mostly in our burn critical care COVID-19 patients. Corticosteroids 
such as Dexamethasone and Methyl-prednisolone have recently been added to our 
COVID-19 treatment protocols in the setting of severe inflammatory responses 
and/or hypoxemia (blood oxygen saturation < 90%). Convalescent plasma has also 
been added to the therapeutic regimen of deteriorating burn critical care cases. All 
our adult patients (ward or ICU, with or without COVID-19) have been receiving 
pharmacological thromboprophylaxis (low molecular weight Heparin, standard-
dose unfractionated Heparin) unless there were contraindications.
Frequent use of antibiotics without clear indications is not anymore recom-
mended. However, they have often been used in burn critical care cases with wors-
ening clinical conditions. All our patients receive the usual dose of daily vitamin C, 
per standard burn treatment protocols. Our current COVID-19 guidelines have not 
yet recommended high dose vitamin C.
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Concomitant severe burn and COVID-19 might complicate the clinical presenta-
tion and hospital course.
This dictates multidisciplinary approaches to risk stratify, screen, assess, and 
manage coexisting diseases. Additionally, appropriate preparations and careful 
precautions need to be executed in burn units to prevent COVID-19 exposure and 
transmission to limit potential adverse outcomes.
The potential detrimental consequences of concomitant burn and COVID-19 sug-
gest mandating extra precautions and sophisticated strategies which need to be imple-
mented in burn units. Such policies help prevent infection, recognize different types of 
exposure, establish detailed and systematic protocols on proper diagnosis and manage-
ment. The key steps include the fast and careful patient screening for COVID-19 on 
arrival, frequent screening of hospital staff, obtaining detailed history on travel risk 
factors in two weeks prior to the admission, assess for fever or other respiratory signs 
and symptoms before or during hospitalization with continuous clinical surveillance, 
personal protective equipment (PPE) in all areas with proper social distancing, provi-
sion of disinfectants and sanitation equipment, and staff travel restrictions [15, 16].
With an ongoing COVID-19 pandemic, SARS-CoV-2 infection might be a 
preceding, concomitant, or subsequent disease in addition to other various medical 
problems or traumas such as burns. Thorough risk stratification and multidis-
ciplinary approaches to the strategic management of comorbid conditions are 
paramount to prevent possible worsening outcomes.
Current evidence demonstrated sensitivity rates of less than 70% for all COVID-
19 diagnostic tests including RNA RT-PCR, total antibody, IgM, and IgG at the first 
week of symptom onset. In addition, the test-positive result rates of RNA RT-PCR 
tests (currently the most performed test in the UK) varies depending on the sam-
pling technique (eg. oropharyngeal swab, NP swab, bronchoalveolar lavage) and 
timing of the test from symptom onset significant presence of false-negative tests 
should always be taken into consideration pending the development of validated, 
highly sensitive and specific tests.
All healthcare workers and patients should attempt to deliver care whilst ensur-
ing protection from disease transmission by any means available. All burns services 
should anticipate and plan to continue delivering patient care whilst taking social 
distancing and shielding measures into account.
The shocking speed with which the COVID-19 pandemic has exploded, and the 
scale of strategic planning required to cope make it very difficult for systems to pre-
pare adequately. In many places, the critical care demand will create sudden scarcity 
which will impact the capacity to provide critical care for burns. This obligates each 
burn centre to prepare for burn care under austere conditions. In cases of massive 
COVID-19 disease, the burn centre will become an important cache of personnel, 
space, and equipment. Burn centre leadership should actively engage in local and 
regional strategic planning. Importantly, the burn community should seek ways to 
help one another through the coming challenge. The present collection of experi-
ences aims to achieve the goal of early communication among burn leaders in order 
to disseminate knowledge rapidly and fast-track best practices.
SARS-CoV-2 screening and prevention strategies need to be implemented 
at burn care centres, both outpatient and inpatient settings during the current 
COVID-19 pandemic. This is due to the substantial vulnerability of burn casualties 
to infection and the ease of transmission among them.
The effectiveness of the adopted measures during the COVID-19 epidemic 
outburst allowed our Burn Unit to preserve its clinical and surgical activity simulta-
neously safeguarding patients and hospital personnel from contagion risk, despite a 
high rate of admitted critical patients and the geographical position in the centre of 
an epidemic area.
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3.1 Medical and surgical approach in the COVID-19 burn patient
Medical treatment of burn patients and COVID-19 patients show an overlap. The 
low number of treated cases could not allow any consideration about the absence of 
COVID-19 complications in burned patients. At the same time, we have to underline 
that several therapeutic approaches that seemed to improve Sars-CoV-2 affected 
patients are common to severely burned patients.
• Low molecular weight heparin: Treatment with LMWH is mandatory because 
both burn condition and COVID-19 infection increase the risk of thrombosis.
Significant inflammation is present in patients with SARS-CoV-2 infection. 
There is the elevation of IL-6 levels, C-reactive protein, and erythrocyte 
sedimentation rate, and fibrinogen.
Since the tropism of the virus is for ACE2 receptors, this determines endothelial 
cell activation and disruption of the antithrombotic state [2].
• Antibiotic treatment: Broad-spectrum intravenous antibiotics are adminis-
tered both for the increased risk of sepsis in burn patients and prophylactically 
in COVID-19 patients to avoid opportunistic infections.
• Plasma transfusion: Plasma transfusion is a life-saving and fundamental treat-
ment in burn patients because it represents the best resuscitation fluid due to its 
capability to restore intravascular volume status and treat the endotheliopathy. 
Hyperimmune plasma from COVID-19 convalescent was also suggested as a 
potential treatment for severe COVID-19 so, even though we have not experi-
enced such treatment in our cases, it could be possible to consider the treatment 
of burn patients with severe SARS-CoV-2 infection by hyperimmune plasma.
• Immunoglobulin: Depressed serum immunoglobulin levels following severe 
burns may lead to subsequent infectious complications following such injuries 
so the administration of immunoglobulin in our therapeutic approach in major 
burns is common (Pentaglobin® at 100 ml rate three times a day for three 
days). At the same time immunomodulation with polyclonal preparation of 
immunoglobulins as adjuvant therapy in SARS-CoV-2 mild and severe pneu-
monia has been detected as efficacy in several cases [38, 39].
At the same time about the medical approach, we have to emphasize the  
mismatch between the important fluid resuscitation necessary for burn 
patients and the fluid restriction that is needed in SARS-CoV-2 pneumonia.
In the surgical approach to COVID-19 burned patients we have marked some 
important aspects to be considered:
• Necrectomy approach: Due to the necessity to reduce operating time and at the 
same time to be efficient with necrectomy we increased the use of enzymatic 
debridement (Nexobrid ®- Mediwound Germany GmbH) which allows an 
efficient and selective debridement with less blood loss [40].
• Hydrodebridement: We have avoided the use of hydro-debridement (such 
Versajet®) for wound bed preparation due to the necessity to have not spread-
ing of virus particles into operating theater and on objects
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• Laparoscopic procedures: When laparoscopic procedures were necessary (eg. 
Protection colostomy) we avoided performing because of the high risk of con-
tamination with the insufflate air and we preferred the laparotomy approach
• Tracheostomy: To perform a tracheostomy on COVID-19 patients it’s neces-
sary a well-trained and experienced surgeon with a strict collaboration with 
an anesthesiologist in all parts of the procedure, in particular, to avoid any air 
spreading from the tube.
• Personnel and equipment: Personnel must be reduced to the minimum 
possible number with a very precise surgical planning. The equipment must be 
the same as in the COVID-19 ward unit and because of the high temperature 
needed during burn patient operations and the physical efforts, it’s mandatory 
to perform early surgical procedures.
• Pathways: Dedicate pathways must be planned for COVID-19 positive patients 
from and to the OR and must be separated from regular pathways for non-
COVID-19 patients.
• Air circulation and operating room preparation: Air circulation has to be 
achieved by using dedicated filters and numerous air exchanges. The OR must 
be equipped with the minimum instruments available and with easily sterilized 
tools, as it needs accurate disinfection after every procedure.
4. Conclusion
In the early weeks of the pandemic, with the first cluster of cases detected on 
21th and 22th of February and a national quarantine declared on March 8th, the 
Italian National Health System found itself in a very stressful situation, counting a 
high number of the greatest number of cases and deaths and requiring an intense 
effort to secure bed availability in the hospitals and the ICUs.
Even if our elective activity was reduced to the correction of burn sequelae, 
urgent and emergent activities greatly increased since many other centres in North 
Italy could not accept burn patients anymore due to ICU bed lacking or furthermore 
for incapability to accept and treat COVID-19 positive patients.
To avoid a possible spreading of SARS-CoV-2 inside the Burn Unit, and to reduce 
the risk patients and health workers were submitted to, since the beginning of the 
emergency period we developed a protocol for the acceptance of all the new patients 
and the surveillance of the hospitalized ones [17].
This protocol was elaborated gathering guidelines and suggestions reported by the 
first Burn Centers involved in COVID-19 infection management [41, 42]. It antici-
pated the general prevention and management indications established by the Medical 
Direction of the University Hospital of Padua, which followed the most updated 
Italian Government and International literature guidelines at the time [18, 19].
Three principles are the pillars of this protocol: patients’ history (suggestive 
symptoms or contact with cases are themself sufficient causes for isolation, even 
if the test performed is negative), rapid testing, and isolation in a dedicated room 
until the test response.
Our Burn Unit Centre is a third level facility, responsible for the acceptance and 
treatment of all major burns in an area with a population of approximately 5 million 
people. When the response timing did not interfere with the urgent treatment, we 
asked the patient to be tested by the sending hospital or by our emergency room.
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For emergency cases instead, with major burns, our microbiological lab granted 
us a preferential route to obtain the results of the swabs within 90 minutes, while 
the patients were kept in isolation in a quarantine room or the operatory room if 
intubated, before being moved to the Ward, semi-ICU or ICU according to their 
conditions.
While since the beginning of the epidemic we decided to stop any outside visits 
to inpatient rooms, encouraging the use of phone or video calls to communicate 
with relatives, an exemption was made for pediatric cases, where the caregiver was 
tested simultaneously with the child or as soon as he arrived, staying in the moni-
toring room till the swab’s result.
The nucleic acid detection through reverse transcription qualitative PCR was 
the only method accepted for the laboratory diagnosis, usually via the collection of 
nasal and pharyngeal swabs but also via BAL in ventilated patients, which proved to 
be a more sensible detector [43].
Once confirmed negative, the patients are finally moved to the Burn Unit 
strictly monitored for 14 days as recommended by the World Health Organization 
(WHO) [44].
Considering no SARS-CoV-2 outbreak has happened in our Burn Unit since the 
beginning of the double testing, despite the second wave of COVID-19 Italy has 
experienced from November 2020, we can consider it an appropriate way of manag-
ing SARS-CoV-2 screening on hospitalized patients and healthcare workers.
COVID-19 infection in burn patients might worsen the clinical outcome making 
medical care, even more, demanding, with the necessity of multidisciplinary care.
Management of surgical patients affected or potentially affected by SARS-CoV-2 
requires clear protocols that must be shared with health care staff in order to be 
implemented. Careful observation of safety rules must be present at all times to 
avoid infection spread. All non-emergency procedures should be postponed until 
a negative RT-PCR test is available for the patient. Clearly, every measure is work-
demanding and requires very high compliance to the rules applied, however, follow-
ing protocols will be the only way to go back to normal activity in the shortest time 
possible.
Currently, the development of at least 7 different vaccines based on 3 platforms 
and their entry into the market represents the best hope for the global population to 
reach the herd immunity necessary to stop the viral spread.
The mass vaccination program started in December 2020. Despite clinical tri-
als presenting high levels of efficacy of several COVID-19 vaccines, like all other 
vaccines, they will not be completely effective.
The development of other variants resistant to immunization and how many 
people get vaccinated are just a few of the possible variants to be included in the 
complex evaluation of the global success of the vaccination process.
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